CAS Medical Systems, Inc. Wins a Legal Round Against Covidien plc's Nellcor

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A federal judge tosses 1 count of a patent infringement lawsuit filed by Covidien's Nellcor subsidiary against CAS Medical over patient monitoring technology. CAS Medical (NSDQ:CASM) won a round in a legal battle with Covidien's (NYSE:COV) Nellcor patient monitoring subsidiary over technology used to measure oxygen levels in the brain, after a federal judge in Michigan tossed a breach-of-contract claim against CasMed. Nellcor sued CasMed in late 2011, alleging that its Branford, Conn.-based rival broke their deal settling a patent infringement lawsuit by protesting the validity of the patent, the "'065 patent," during a re-examination by the U.S. Patent & Trademark Office.

Help employers find you! Check out all the jobs and post your resume.

Back to news